Junyuan Huang, Yinhuang Gao, Shiqin Jiang, Minghong Chen, Zhiyan Qin, Ting Yu et al. Reversal of acquired osimertinib resistance by YAP inhibition in lung cancer is associated with lipid metabolic reprogramming. // Toxicology and Applied Pharmacology. – 2027. – DOI: 10.1016/j.taap.2026.118098. – URL: https://doi.org/10.1016/j.taap.2026.118098
Junyuan Huang, Yinhuang Gao, Shiqin Jiang, Minghong Chen, Zhiyan Qin, Ting Yu, Tianli Nong, Luyao Yang, Min Huang, Yuyan Luo, & Jing Jin (2027). Reversal of acquired osimertinib resistance by YAP inhibition in lung cancer is associated with lipid metabolic reprogramming. Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2026.118098
Junyuan Huang, et al. “Reversal of acquired osimertinib resistance by YAP inhibition in lung cancer is associated with lipid metabolic reprogramming.” Toxicology and Applied Pharmacology, 2027. doi:10.1016/j.taap.2026.118098.
@article{Huang2027,
title = {Reversal of acquired osimertinib resistance by YAP inhibition in lung cancer is associated with lipid metabolic reprogramming},
author = {Huang, Junyuan and Gao, Yinhuang and Jiang, Shiqin and Chen, Minghong and Qin, Zhiyan and Yu, Ting and Nong, Tianli and Yang, Luyao and Huang, Min and Luo, Yuyan and Jin, Jing},
journal = {Toxicology and Applied Pharmacology},
year = {2027},
doi = {10.1016/j.taap.2026.118098},
url = {https://doi.org/10.1016/j.taap.2026.118098}
}